Egetis Therapeutics’ SEK 210 Million Directed Share Issue

Federica Tiefenthaler
Tagged:

Vinge has advised Egetis Therapeutics AB on the deal.Egetis Therapeutics AB (publ), an innovative and integrated pharmaceutical company focusing on projects in late-stage development for commercialization for…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

This content is for Standard 1 Year members only.
Login Join Now